News

Mérieux NutriSciences Expands Food Testing Reach with Major Acquisition

Mérieux NutriSciences Expands Food Testing Reach with Major Acquisition

Mérieux NutriSciences Expands Food Testing Operations

Mérieux NutriSciences, a global leader in food safety and quality, has taken significant steps to cement its position in the food testing industry by entering into a strategic agreement to acquire the food testing business of Bureau Veritas. This move is set to bolster Mérieux NutriSciences’ operations, allowing it to generate revenues exceeding $1 billion and forging a stronger presence in the food testing, inspection, and certification (TIC) market.

Strategic Deal Enhances Global Presence

This acquisition is a pivotal step forward for Mérieux NutriSciences, effectively doubling its market presence in the Asia Pacific region and extending its operations to new territories with promising growth potential. With this agreement, Mérieux NutriSciences aims to create a broader network, providing its extensive services to food sector customers across numerous countries.

Scope and Impact of the Acquisition

The reach of this acquisition encompasses Bureau Veritas’ comprehensive food laboratory testing operations, which include microbiological and chemical analysis, as well as molecular testing. Currently, these services are offered through a robust network comprising 34 laboratories and over 1,900 skilled professionals across diverse regions, including the Americas, Africa, and Asia Pacific.

Keeping Up with Industry Demand

Mérieux NutriSciences actively engages in discussions with AsureQuality, a New Zealand based provider specializing in food assurance, to maintain ongoing joint ventures initially established between Bureau Veritas and AsureQuality in various locations. This approach further reinforces their commitment to expanding their influence and capabilities in the industry.

Capitalizing on Market Growth

As a pivotal player in the $15 billion global food TIC market, Mérieux NutriSciences sees a consistent annual growth of about 5%. This increase is primarily driven by a surging consumer demand for enhanced food safety and quality, coupled with stricter regulations aimed at ensuring sustainability and traceability within the food supply chain. Mérieux NutriSciences boasts a collaborative network of nearly 140 laboratories and a workforce exceeding 10,000 employees, enabling it to meet the evolving requirements of this expanding industry.

Leadership Insights

CEO Nicolas Cartier expressed, "The acquisition of Bureau Veritas' food testing business marks a pivotal milestone for Mérieux NutriSciences. It will significantly enhance our ability to serve our customers, ultimately increasing our contribution to the safety, quality, and sustainability of global food systems. Once the transaction concludes, our team will be even stronger in our mission: 'Better Food. Better Health. Better World.'"

Collaborative Partnership for a Sustainable Future

Bureau Veritas CEO Hinda Gharbi shared her optimism about the partnership, stating, "We are excited to collaborate with Mérieux NutriSciences, a leader in Food testing, whose global footprint and proven expertise is a perfect match for our food business, enabling it to thrive while contributing to safer, healthier, and more sustainable food systems."

Closing Timeline and Future Prospects

This acquisition is projected to finalize by the end of the fourth quarter of 2024, contingent on fulfilling customary closing conditions, including necessary regulatory approvals. This transaction lays the groundwork for Mérieux NutriSciences to enhance its comprehensive service offering and extend its global footprint within the food industry.

About Mérieux NutriSciences

With over 50 years of expertise, Mérieux NutriSciences is committed to addressing contemporary challenges faced by the food industry. The company understands that beyond reliable analytical results, clients require innovative solutions for creating safer, healthier, and more sustainable food systems. Operating more than 100 accredited laboratories and employing a dedicated team of over 8,000 worldwide, Mérieux NutriSciences aims to deliver on its promise of better food, better health, and a better world.

Frequently Asked Questions

What is the main focus of Mérieux NutriSciences?

Mérieux NutriSciences focuses on food safety, quality, and sustainability, providing testing and certification services globally.

What will the acquisition of Bureau Veritas achieve?

This acquisition aims to enhance Mérieux NutriSciences' capabilities in food testing, significantly broadening its operational scale and geographic reach.

How many laboratories does Mérieux NutriSciences operate?

Mérieux NutriSciences operates more than 100 accredited laboratories worldwide.

What is the projected timeline for the acquisition?

The transaction is expected to close by the end of the fourth quarter of 2024, subject to regulatory approvals.

Who leads Mérieux NutriSciences?

Nicolas Cartier serves as the CEO of Mérieux NutriSciences, guiding the company's strategic initiatives.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 28

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 153

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 175

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 92

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 184

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 345

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 177

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading

Top 5 Most Recently Viewed Articles

John Couris of Florida Health Sciences Center Wins Notable Honor

Updated Category News Views 257

Recognizing Leadership in Healthcare Innovation John Couris, the president and CEO of Florida Health Sciences Center, has recently earned a distinguished accolade by being named one of the 2025 "100 Most Influential People in Healthcare" by Modern Healthcare. This recognition underscores Couris' exceptional leadership and commitment to improving healthcare services across...

Continue Reading
Recent Bullish Trends in Vale Options Trading Activity

Updated Category News Views 179

Significant Options Activity in Vale (VALE) In recent trading sessions, notable investors have shown a bullish outlook on Vale (NYSE: VALE), and this trend is crucial for retail traders to observe. Through the analysis of options history, it has become evident that an uptick in activity from large-scale investors is attracting attention. These trades suggest that market...

Continue Reading
MOVA Launches Innovative Smart Outdoor Tech at Equip Exposition

Updated Category News Views 369

MOVA Unveils Smart Outdoor Solutions MOVA, a prominent name in smart technology, made a striking entrance at Equip Exposition 2025 by introducing its latest advancements in outdoor solutions. Among the star attractions were the groundbreaking LiDAX Ultra Series robotic lawn mowers, Unified 60V Battery Garden Tools, and the EvoLife Series Power Tools. These new products...

Continue Reading
Transforming Fate: Lone Star PACE Launches New Financing Program

Updated Category News Views 178

Lone Star PACE Launches Innovative C-PACE Program Lone Star PACE has been entrusted with administering the new Commercial Property Assessed Clean Energy (C-PACE) program for the City of Fate. This progressive step is part of a significant initiative aimed at enhancing sustainability and economic growth in Texas. Supporting Sustainable Development This initiative...

Continue Reading
Revolutionary Refrigerator Juicer Designed for Everyday Use

Updated Category News Views 166

Introduction to the Innovative Refrigerator Juicer The inventive spirit has led to the creation of a new kitchen companion that simplifies the process of enjoying freshly squeezed juice. This refrigerator juicer, designed to be convenient and user-friendly, aims to revolutionize how households treat juice. The creator of this innovative appliance had a vision: to create a...

Continue Reading